January 2018
Volume 31, No. 1 |
|
|
|
|
|
| 2018 BIOPHARMA FOCUS |
Rita C. Peters
Scientific advances and renewed investment may infuse biopharma for growth.
read more
Cynthia A. Challener
Gene therapies highlight FDA new drug approvals in 2017.
read more
|
|
|
BioPharm International January Issue
|
|
Jill Wechsler
Policy makers look to boost generic drugs, curb opioid abuse, and maintain incentives for innovation.
read more
Jim Miller
The industry will see an impact from financing, M&As, advanced therapies, generic drugs, and the retail market in 2018.
read more
|
|
|
| UPSTREAM PROCESSING |
Feliza Mirasol
Recent investments show expansion activity in cell culture facilities.
read more
|
|
|
| DOWNSTREAM PROCESSING |
Cynthia A. Challener
Advances in TFF and single-use systems help advance UF/DF on the continuous processing path.
read more |
|
|
| FLUID HANDLING |
Gregg Johnson
Proper selection and installation optimizes fluid system performance.
read more
| PEER-REVIEWED |
Yuanyuan Cui, Zheng Huang, Jack Prior
The authors present a robust and easy-to-implement chromatography column performance assessment method, called direct transition analysis (DTA).
read more
|
|
|
| ANALYTICS |
Feliza Mirasol
Conducting stability testing on APIs/finished drug product helps ensure shelf-life storage.
read more
|
|
|
| OPERATIONS |
Amber Lowry
New technological advancements seek to improve pharmaceutical process monitoring and control.
read more
| SERIALIZATION |
Agnes Shanley
Open standards based on GAMP and GS1 will soon be released and more companies are moving beyond basic compliance.
read more
| FROM THE EDITOR |
Rita C. Peters
BioPharm International will mark 30 years of biopharma industry progress and challenges in 2018.
read more
| ASK THE EXPERT |
Siegfried Schmitt
Enterprise-wide processes, procedures, and systems are the keys to data integrity and peace of mind, according to Siegfried Schmitt, PhD, principal consultant at PAREXEL.
read more
|
|
|
| EVENTS |
Feb. 7–8, 2018
Feb. 11–14, 2018
Mar. 12–14, 2018
more events
|
|
|
|
|